The Federal Trade Commission, which opposed the tie-up, cheered the news on Thursday. Previously, the agency had warned state lawmakers about the dangers of shielding hospital mergers from antitrust enforcement.
Michael Sanky, global industry lead of healthcare and life sciences at Databricks, outlines how technology and healthcare leaders can harness artificial intelligence to equitably help patients.
LHC’s delisting, a sign that the deal’s close could be imminent, doesn’t come as a surprise, as the Nasdaq notified the home health provider it wasn’t in compliance with the stock market’s listing standards in January.
Addressing the education pipeline is one thing that legislators can focus on to improve nurse and physician shortages, medical school and health system leaders said during a Senate committee hearing.
At issue is the hospitals’ use of the “Meta Pixel” website code, which potentially analyzed, gathered and shared the protected medical data of hundreds of thousands of patients, in violation of HIPAA, according to the suit.
The acquisition comes on the heels of a thwarted attempt by HCA to purchase the Utah sites last year. The FTC was successful in its attempt to block the deal after it alleged that it would harm patients.
The earnings come two days after CHS announced that it experienced a security breach that potentially exposed the health information of 1 million patients.
BioPlus will now operate as a part of the insurer’s pharmacy benefit manager, CarelonRx.
The pilot programs could allow adjusted payments for drugs cleared under accelerated approval and help states manage the costs of gene therapies.
Privately offered Medicare Advantage plans “do not often provide a clear reason for the denial of coverage, and rarely offer any visibility into the evidence and methodology,” trade group MDMA and Boston Scientific said.